RWE Program Offers Sponsors Chance At Novel Uses, But In Exchange For Disclosing Proposals

The disclosure requirement to participate includes an option for the US FDA to include the ideas on new regulatory uses for real-world evidence in a guidance or speak about them at public forums in order to ‘promote innovation.’